RecruitingNCT06394284
MDMA-assisted therapy or trauma-focused therapy for veterans with PTSD and moral injury
About this title
Read the official source — NCT06394284Medication studyIsrael
Understand this study
- Listed locations
- JerusalemSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 18, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 60
- Sponsor
- Herzog Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Israel
- Age range
- Not clearly listed
- Official registry ID
- NCT06394284
- Official title
Show the full official title
IISPT2: Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and MI
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Jerusalem
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Herzog Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including MDMA-AT.
Is this study still recruiting?
The registry lists this study as recruiting.
